MedCity News December 12, 2024
Marissa Plescia

Noom will begin offering oral medications for weight loss, starting with Metformin. This can support those who have a needle version or have a lower body mass index than indicated for GLP-1s.

Noom, a digital health company for chronic disease prevention, will begin offering oral medications for weight loss through its Noom Med program, it announced Thursday.

New York City-based Noom helps people build healthy habits through psychological tools like food tracking, coaching and community. Through Noom Med, patients get access to one-on-one messaging with weight loss clinicians, medication prescriptions, a community of patients, medication management and educational content. They can also get prescriptions for GLP-1s when appropriate.

With the inclusion of oral medications for weight loss, Noom Med can...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
How has U.S. Spending on Health Care Changed Over Time?
Merck enters $2B licensing deal for weight loss drug
How Medicare Negotiated Drug Prices Compare to Other Countries
The Fed's Warnings On Inflation Are Bad News For Biotech Startups
AI Tech Firm SandboxAQ Adds $300M to Ramp Up Development of LQMs for Drug Discovery & More

Share This Article